“I am sorry, but your time has expired. Have a nice day!” Nope, not a friendly message from a parking meter app. This was from Deathclock.com, a site that purports to tell folks their predicted date of death based primarily on their date of birth. Mine was May 3, 2020 according to “the clock”. Uh, I don’t think so… Clearly—and fortunately for me as I write this blog—the date was more than a little off. Frankly, predicting a date of death is not something to laugh about. Too many folks facing serious illnesses deal with the burden of their mortality… Read More »Message From “The Deathclock”: “Your Time Has Expired.” Really???
One cannot ignore that fundamental change is coming to how we deliver cancer care. And although we don’t know how all of this will work out, we should be concerned that with change we run the risk there will be folks who could be left behind. And that is not a good thing. This past week’s annual conference for the National Comprehensive Cancer Network—an organization I admire for its efforts to keep cancer treatment guidelines up to date in real time—gave some hint as to how these shifts are taking hold. Usually this is a meeting chock full of updates… Read More »How We Deliver Cancer Care: Time For A Change?
With all the talk about COVID vaccinations, cancer patients have to be asking what it means for them. And aside from some general reassurances, there is a lot we don’t know about how effective those vaccines will be in patients with cancer. What we do know that many are at risk of severe adverse outcomes should they become infected with the virus itself and vaccines are one among several strategies to keep patients with cancer safe from the ravages of COVID and its consequences. There are a couple of important points to keep in mind when we talk about patients… Read More »COVID-19, Vaccines, and Cancer: We Don’t Have All The Answers
Health equity has been top of mind for many this past year, in large part because of the impact of the pandemic especially on people of color and underserved communities. Now that we recognize that health equity is not a reality for far too many, the question remains what are we actually going to do to make certain that everyone has the tools they need to pursue a life of health and healthy behaviors? And more specifically, what are we going to do in the cancer care sphere—from prevention to diagnosis to treatment to end-of-life care—to address the glaring inequities… Read More »An Actionable Framework to Address Cancer Care Disparities: A Call To Action
Getting Back To Cancer Screening: It’s Time To Give Priority To Those Most In Need, Not Those With The Loudest Voice
“How will be certain coming out the pandemic that those who should be a priority for cancer screenings based on risk and need in fact get to the head of the line? And how will we be certain that those who lack voice in the healthcare system are heard and their needs addressed?” That was the question I asked frequently a year ago as we went into the initial shutdown phase as a result of COVID-19. It was a time when there was fear and a lack of understanding about the pandemic, when resources had to be shifted to acute… Read More »Getting Back To Cancer Screening: It’s Time To Give Priority To Those Most In Need, Not Those With The Loudest Voice
It is hard to believe it was just a year ago when all of this started. And now to realize that after everything that we have gone through we are still not near the end of the journey. One year ago I had just started having conversations with knowledgeable colleagues about the threat of this new potentially fatal virus. It was the beginning with cases of a new viral illness reported out of China, a killer virus that was still very much a theoretical threat of what could happen here in the United States. The back-of-the-envelope COVID-19 death projections we… Read More »The Tragic Anniversary of COVID-19
“Biden’s Covid-19 Plan Is Maddeningly Obvious: You can’t help but wonder why the Trump administration left so many of these things undone.” That’s the headline for Ezra Klein’s opinion column in today’s New York Times. It is a question many have been pondering for months. And although I had a thought as to why it was so, I didn’t want to share because at its heart it was so outrageous and unbelievable: Maybe, just maybe, it was all intentional. They planned it this way. It was—simply put—another “Big Lie.” Why was this Big Lie also so successful? Just think where… Read More »COVID Truth In A Post-Truth World: Is It Another Big Lie?
We are facing a surge in corona virus cases. Hospitals are at their limits throughout the United States. Nurses, doctors, hospital staffs are overwhelmed. They are tired, and relief is not in sight. Does that mean we will start seeing health care rationed, especially for cancer patients whose prognosis may be uncertain? Sadly, that may be the case over the next several weeks if we don’t reverse our current course to disaster. During the early days of the COVID19 pandemic one of my worst fears was the possibility that cancer patients could not get hospital treatment if needed as a… Read More »Does COVID Winter Mean Rationing Care For Those With Cancer?
Cancer advocacy is not often top of mind, even for patients and families facing active diagnoses and treatments for cancer. However, with the added impact of COVID-19 on our health and well being, advocacy and service in the cancer space is becoming more important than ever. That is one of the messages that came from a webinar I participated in this morning on “Cancer Care Patient Advocacy Perspectives” as part of a series of discussions being presented over the course of several months by the Association for Value Based Cancer Care. Organizations providing advocacy and service to those with cancer… Read More »Cancer Advocacy: A Precious Resource In A Time Of Immense Needs
Hydroxychloroquine has become a part of the COVID story that will not go away. And with another research study reported today in JAMA showing no benefit of the drug in hospitalized patients with COVID-19, the journal asks the fundamental question: Why do we continue to believe this drug has benefit in treating this pandemic illness, and why won’t science prevail? To which we respond: Why are we surprised???? The study, performed by a clinical trial collaborative under the guidance of the National Heart and Lung Institute of the National Institutes of Health included 479 patients in 34 hospitals around the… Read More »Hydroxychlorqine for COVID-19: Time To Move On?